38 research outputs found
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Get PDFBackground:
The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms.
Methods:
International, prospective observational study of 60â109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms.
Results:
âTypicalâ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (â€â18 years: 69, 48, 23; 85%), older adults (â„â70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each Pâ<â0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country.
Interpretation:
This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men
La suspension d'une autorisation de mise sur le marché en France et les recours possibles pour le titulaire de l'autorisation (l'exemple du KetumŸ gel)
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
La prise en charge des médicaments à l'hÎpital (les médicaments hors GHS [Groupes homogÚnes de séjour])
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
La contrefaçon de médicaments (analyse de la situation européenne et africaine)
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
Le conditionnement des médicaments en France (la réglementation applicable et un cas pratique de projet modifiant le packaging)
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
La diffusion de l'information médicale par les entreprises pharmaceutiques (nouveaux médias, nouvelle législation)
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
Le complément alimentaire (des particularités juridiques au marché économique d'un produit à la frontiÚre du médicament)
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
Publicité comparative et médicament générique
No full textPARIS-BIUP (751062107) / SudocSudocFranceF
Les sociétés de pharmaciens d'officine (vers une révolution du schéma actuel ?)
No full textLILLE2-BU Santé-Recherche (593502101) / SudocSudocFranceF
